Locations:
Search
The retrospective study identifies factors that influence disease-free and overall survival
62% of patients were progression-free at 18 months post-transplantation
Focused ultrasound is paired with ALA to utilize sonodynamic therapy to target cancer cells
Study assesses the impact of donor source and post-transplant prophylaxis for patients receiving a hematopoietic cell transplant
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Reassessing antibiotic dosage and type and restoring gut biome could improve survival rates
Immunotherapy is preferred initial treatment for majority of patients
Recommendations focus on selecting the right biomarkers for the right setting
Pancreas and spleen removed to minimize risk of pancreatic cancer
A recent case study illustrates surgical intervention for treating recurrent bladder cancer
Patients with ER-positive invasive lobular cancer face worse disease-free survival and overall survival
Advertisement
Advertisement